Skip to content

Probiotics in the Treatment of Gum Disease

Probioticinfluence in the Treatment of Periodontal Disease in Medically Compromised patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6cghbsd
Enrollment
Unknown
Registered
2023-07-25
Start date
2023-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases

Interventions

This is a parallel randomized controlled clinical study with two arms, double-blind (n=40). Experimental group: 20 volunteers who will undergo non-surgical periodontal treatment associated with topica

Sponsors

Universidade Estadual de Ponta Grossa
Lead Sponsor
Curso de Odontologia - Universidade Estadual de Ponta Grossa
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The inclusion criteria for the study will be patients with mild to severe periodontal disease. Over 18 years of age. Under medical follow-up due to chronic diseases. The criteria for classifying the patient's condition as periodontal disease are based on attachment loss, probing depth, and pattern of bone loss. Stage I has interproximal attachment loss of 1-2 mm and probing depths of up to 4 mm. Stage II has interproximal attachment loss of 3-4 mm and probing depths of up to 5 mm. Stage III and IV have interproximal attachment loss of 5 mm or more, with bone loss and tooth loss

Exclusion criteria

Exclusion criteria: Not eligible for the study: Patients undergoing periodontal or orthodontic maintenance. Pregnant or lactating women. Patients with uncontrolled severe systemic disease. Psychiatric problems. Local pathological alterations. Volunteers requiring tooth extraction. Need for antibiotic prophylaxis. Patients who have used analgesic and anti-inflammatory drugs up to 12 hours before treatment. Alcoholism. Smokers. Dentin hypersensitivity or other pulpal pathologies

Design outcomes

Primary

MeasureTime frame
To verify if the local use (intrabuccal) of probiotics associated with non-surgical periodontal treatment contributes to the periodontal clinical parameters in patients with chronic systemic diseases.

Secondary

MeasureTime frame
To verify whether probiotic therapy in the treatment of periodontal disease contributes to improved quality of life after performing non-surgical periodontal treatment.;To verify whether probiotic therapy in the treatment of periodontal disease contributes to stability of hemodynamic parameters (systemic blood pressure, heart rate, and oxygen saturation) after non-surgical periodontal treatment.;To verify whether probiotic therapy in the treatment of periodontal disease contributes to improvement in masticatory performance after treatment.;Check the presence of residual calculus after non-surgical periodontal treatment.

Countries

Brazil

Contacts

Public ContactElisangela Montes

Hospital Universitário - Universidade Estadual de Ponta Grossa

hu.dac@uepg.br+55 (42) 3219-8888

Outcome results

None listed

Source: REBEC (via WHO ICTRP)